Cancer mutationscape: revealing the link between modular restructuring and intervention efficacy among mutations.

Autor: Plaugher, Daniel¹ (AUTHOR) plaugher_dr@uky.edu, Murrugarra, David² (AUTHOR)

Publikováno v: NPJ Systems Biology & Applications. 7/13/2024, Vol. 10 Issue 1, p1-11. 11p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Investigating the Effect of Changes in Model Parameters on Optimal Control Policies, Time to Absorption, and Mixing Times.

Autor: Johnson, Kathleen, Plaugher, Daniel, Murrugarra, David

Publikováno v: Letters in Biomathematics; 2023, Vol. 10 Issue 1, p193-206, 14p

Methionine Restriction Reduces Lung Cancer Progression and Increases Chemotherapy Response.

Autor: Naughton KJ; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536., Song X; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536., Childress AR; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536., Skaggs EM; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536., Byrd AL; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536., Gosser CM; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536., Esoe DP; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536., DuCote TJ; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536., Plaugher DR; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536., Lukyanchuk A; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536., Goettl RA; Markey Cancer Center, University of Kentucky, Lexington KY 40536., Liu J; Markey Cancer Center, University of Kentucky, Lexington KY 40536.; Department of Internal Medicine, University of Kentucky, Lexington KY 40536., Brainson CF; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington KY 40536.; Markey Cancer Center, University of Kentucky, Lexington KY 40536.; Corresponding author.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 23. Date of Electronic Publication: 2024 Jul 23.

EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas.

Autor: DuCote TJ; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky., Song X; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky., Naughton KJ; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky., Chen F; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky., Plaugher DR; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky., Childress AR; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky., Gellert AR; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky., Skaggs EM; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky., Qu X; Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia., Liu J; Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia.; Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia., Liu J; Department of Cancer Biostatistics, University of Kentucky, Lexington, Kentucky., Li F; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York University, New York, New York., Wong KK; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York University, New York, New York., Brainson CF; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.

Publikováno v: Cancer research communications [Cancer Res Commun] 2024 Feb 13; Vol. 4 (2), pp. 388-403.